Tara McCrimmon

Dr. Tara McCrimmon

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in Trials
Verified
Journal Article
Open access
PDF file
TMTara McCrimmon
Tara McCrimmon
SWSusan Witte
Susan Witte
GMGaukhar Mergenova
Gaukhar Mergenova
TTTerlikbayeva Terlikbayeva
Terlikbayeva Terlikbayeva
Sholpan PrimbetovaSholpan Primbetova
Sholpan Primbetova
NENabila El-Bassel
Nabila El-Bassel
Among women at high risk for HIV and other sexually transmitted diseases (STIs), gender and economic issues limit the impact of behavioral prevention strategies. Women in Kazakhstan with dual risks of sex trading and drug use face elevated risk for HIV and STIs and may benefit from an economic empowerment intervention which combines HIV-risk reduction (HIVRR) education with financial skills-building and asset-building to promote reduced reliance on sex trading for income. The study employs a two-arm, cluster-randomized controlled trial (c-RCT) design. We will use cluster randomization to assign 350 women in approximately 50 cohorts to a traditional four-session HIV-risk-reduction intervention combined with a six-session financial literacy intervention, enrollment in a 24-session vocational training program and receipt of matched savings (HIVRR+MF); or to the four-session HIV-risk-reduction intervention alone (HIVRR). Repeated behavioral and biological assessments will be conducted at baseline, then at 6, 9, and 15 months post randomization/session 1. This study responds to an identified need in the academic literature for rigorous testing of structural interventions, including combination microfinance and HIV-prevention interventions. ClinicalTrials.gov, ID: NCT02406482 . Registered on 30 March 2015.

31 October 2022 in Addictive Behaviors
Verified
Journal Article
Closed access
MPMorgan M. Philbin
Morgan M. Philbin
EGEmily R. Greene
Emily R. Greene
NLNatalie J. LaBossier
Natalie J. LaBossier
SMSilvia S. Martins
Silvia S. Martins
TMTara McCrimmon
Tara McCrimmon
PMPia M. Mauro
Pia M. Mauro

19 September 2018 in Journal of Urban Health
Verified
Journal Article
Closed access
PDF file
LGLouisa Gilbert
Louisa Gilbert
LMLynn Michalopoulos
Lynn Michalopoulos
XMXin Ma
Xin Ma
TJTina Jiwatram-Negrón
Tina Jiwatram-Negrón
TTTerlikbayeva Terlikbayeva
Terlikbayeva Terlikbayeva
GMGaukhar Mergenova
Gaukhar Mergenova

8 April 2022 in Global Health: Science and Practice
Verified
Journal Article
Open access
PDF file
TMTara McCrimmon
Tara McCrimmon
ASAnne Sundelson
Anne Sundelson
MDMeruyert Darisheva
Meruyert Darisheva
LGLouisa Gilbert
Louisa Gilbert
THTimothy Hunt
Timothy Hunt
NENabila El-Bassel
Nabila El-Bassel
Introduction: The coronavirus disease (COVID-19) pandemic and resulting lockdowns have disrupted health care service delivery globally. This includes disruptions in harm reduction and HIV service delivery for people who inject drugs (PWID), a population at high risk for not only COVID-19 but also poor HIV and drug-treatment access. However, little is known about these issues in Kazakhstan. We examined harm reduction provider experiences with delivering services and regulatory changes during the COVID-19 pandemic. Methods: We conducted in-depth interviews with 24 nurses, social workers, and doctors serving both HIV-positive and HIV-negative PWID at 13 needle and syringe programs (NSPs) and 4 AIDS Centers (HIV treatments centers) in Kazakhstan from May to August 2020. Participants were asked how the COVID-19 pandemic had impacted their PWID clients’ risks, their organizational environment, and the services offered to PWID over the prior 3–6 months. Thematic content analysis was used to elicit findings. Findings: The COVID-19 pandemic considerably impacted NSP and AIDS Center operations. Participants perceived high risks of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection for themselves and their clients, as well as pandemic-related increases in substance use and HIV risks for clients. Organizations instituted several policy and regulatory changes to adapt to the pandemic, most notably tasking NSPs with delivering HIV medications; these changes necessitated new roles and responsibilities for many providers. Despite this stressful changing environment and increased service demands, participants still shared examples of persistence and resilience as they worked to meet client needs during these challenging times. Discussion: NSPs in Kazakhstan are well-positioned to reach key populations with crucial information and flexible services during the COVID-19 pandemic. However, they need recognition as essential organizations and additional equipment and staff support to protect staff and clients, maintain pandemic-related regulatory changes, and address additional challenges such as overdose prevention among clients. Key Findings As organizations implemented policy and regulatory changes in response to the pandemic, service providers at needle and syringe programs (NSPs) and AIDS Centers (HIV treatments centers) demonstrated flexibility and persistence in taking on new roles and responsibilities while continuing to meet the needs of people who inject drugs (PWID). NSPs are well-positioned to provide services to marginalized groups during the pandemic because they have community connections and flexibility that traditional health facilities may not have. Providers at NSPs were hampered by a lack of resources, limited personal protective equipment access, low salaries, and the designation of NSPs as nonessential services, which forced NSPs to close during the peaks of the pandemic. This underinvestment in NSPs undermines their potential to provide care to key populations during the pandemic. Key Implications Differentiation-of-care approaches are essential to continue reaching marginalized groups during a crisis on the scale of the pandemic, which deeply impacted service provision through traditional medical systems. Kazakhstan’s national health care policy makers should increase resources and support for NSP operations during COVID-19 to ensure that PWID continue to receive necessary services for HIV and harm reduction.

1 October 2023 in AIDS Education and Prevention
Verified
Journal Article
Closed access
TMTara McCrimmon
Tara McCrimmon
VFVictoria Frye
Victoria Frye
MDMeruyert Darisheva
Meruyert Darisheva
LSLaura Starbird
Laura Starbird
OCOlivia Cordingley
Olivia Cordingley
BWBrooke S. West
Brooke S. West

23 July 2024 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
TMTara McCrimmon
Tara McCrimmon
TMTrena I. Mukherjee
Trena I. Mukherjee
APAndrea Norcini Pala
Andrea Norcini Pala
GMGaukhar Mergenova
Gaukhar Mergenova
ATAssel Terlikbayeva
Assel Terlikbayeva
SWSusan S. Witte
Susan S. Witte